“…miR‐31 is also up‐regulated in some cancers, acting as an oncogenic miRNA (oncomiR). One well‐documented oncomiR role of miR‐31 was described in colorectal cancers (Cottonham et al, ; Cekaite et al, ; Xu et al, ; Yang et al, ; Ito et al, ; Lei et al, ; Li et al, ; Tateishi et al, ). Some of the miR‐31 targets of colon cancer include important tumor suppressors such as E2F2 (E2F Transcription Factor 2); SATB2 , RASA1 (RAS p21 GTPase activating protein 1), which was recently shown to be targeted by miR‐31 in pancreatic cancer); RHOBTB1 (Rho‐Related BTB Domain Containing 1); and TIAM1 (T Lymphoma and Metastasis Gene 1) (Cottonham et al, ; Sun et al, ; Xu et al, ; Yang et al, ; Li et al, ; Kent et al, ).…”